Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1126 of 1,261
  1. US 6939945

    Synthetic peptides, conjugation reagents and methods

    The Regents of the University of California Β· Granted Sep 6, 2005 Β· Expires Sep 1, 2025

    expired
  2. US 6939878

    Deuterated rapamycin compounds, method and uses thereof

    ISOTECHNIKA INTERNATIONAL INC. Β· Granted Sep 6, 2005 Β· Expires Sep 1, 2025

    expired
  3. US 6939847

    Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

    The Board of Regents of the University of Texas System Β· Granted Sep 6, 2005 Β· Expires Sep 1, 2025

    expired
  4. US 6939549

    Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use

    The Board of Regents for Oklahoma State University Β· Granted Sep 6, 2005 Β· Expires Sep 1, 2025

    expired
  5. US 6936719

    Biaryl compounds as serine protease inhibitors

    BioCryst Pharmaceuticals, Inc. Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  6. US 6936599

    Estriol therapy for multiple sclerosis and other autoimmune diseases

    The Regents of the University of California Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  7. US 6936639

    Nitroxyl progenitors in the treatment of heart failure

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  8. US 6936435

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  9. US 6936448

    Nucleic acids and proteins of a rat ganglioside GM1-specific Ξ±1-2fucosyltransferase and uses thereof

    Northwest Biotherapeutics, Inc. Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  10. US 6936431

    Methods and compositions for inhibiting farnesyl transferase enzyme

    The Board of Regents of the University of Texas System Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  11. US 6936602

    Benzazepine derivatives, process for the preparation of the same and uses thereof

    Takeda Chemical Industries Ltd. Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  12. US 6936731

    Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

    TEVA GyΓ³gyszergyΓ‘r RΓ©szvΓ©nytΓ‘rsasΓ‘g Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  13. US 6936720

    Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  14. US 6936701

    Glycoconjugates and methods

    The Regents of the University of California Β· Granted Aug 30, 2005 Β· Expires Aug 25, 2025

    expired
  15. US 6933108

    Methods and compositions for use in the treatment of filovirus mediated disease conditions

    The Regents of the University of California Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  16. US 6933306

    Hydroxamic and carboxylic acid derivatives

    Darwin Discovery Limited Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  17. US 6933277

    Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  18. US 6933276

    Methods of treating peripheral neuropathies using neurotrophin-3

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  19. US 6933142

    HEC-G1CNAC6ST

    The Regents of the University of California Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  20. US 6933113

    Modulation of endogenous gene expression in cells

    Sangamo Biosciences, Inc. Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  21. US 6933274

    Methods for treatment of diabetes using a peptide analogues of insulin

    Neurocrine Biosciences, Inc. Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  22. US 6933129

    Method for culturing and assaying cells

    Precision Therapeutics, Inc. Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  23. US 6933279

    Orally administered peptides to ameliorate atherosclerosis

    The Regents of the University of California Β· Granted Aug 23, 2005 Β· Expires Aug 18, 2025

    expired
  24. AU 2002257817

    Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] Β· Granted Aug 18, 2005 Β· Expires Aug 13, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.